MedTrace Logo

Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis

NCT06412094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2024-05-14

No results posted yet for this study

Summary

A randomized controlled study in children with AD, divided into three groups: a control group without access to the app, an experimental observational group with the app, and an experimental interventional group with potential investigator supervision. Outcome measures included the SCORAD and the POEM scores.

Conditions

Interventions

OTHER

Standard care

Recommendation of standard treatment plan, according to the clinical severity of the AD, and. are instruction to contact the doctor via messenger for any questions related to treatment recommendations.

BEHAVIORAL

Access to the "AtopicApp" mobile application

Access to the "AtopicApp" mobile application with 1 day after enrollment.

BEHAVIORAL

Virtual oversight through the AtopicApp

Notification of doctor's virtual oversight through the AtopicApp mobile application.

Sponsors & Collaborators

  • Avanta Trading Ltd.

    lead INDUSTRY

Principal Investigators

  • Natalia Migacheva, MD, PhD · Samara State Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-12-26
Completion
2022-12-26

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06412094 on ClinicalTrials.gov